-
公开(公告)号:US20220362380A1
公开(公告)日:2022-11-17
申请号:US17294521
申请日:2020-11-10
Applicant: Cochlear Limited
Inventor: Jonathon Kirk , Daniel Smyth , Ya Lang Enke , Wolfram Frederik Dueck
Abstract: Presented herein are techniques for localized release of systemically circulating therapeutic substances, which combine many of the advantages of systematic and localized administration, while eliminating many of the associated drawbacks. More specifically, in accordance with the techniques presented herein, an electro-responsive biomaterial is systemically administered to a recipient of an electrically-stimulating implantable medical device. The electro-responsive biomaterial comprises a therapeutic substance that is only activated (e.g., released) in the presence of an electromagnetic field generated by the electrically-stimulating implantable medical device.
-
公开(公告)号:US12290660B2
公开(公告)日:2025-05-06
申请号:US17274760
申请日:2019-12-31
Applicant: Cochlear Limited
Inventor: Wolfram Frederik Dueck , Daniel Smyth , Jonathon Kirk
Abstract: An apparatus includes an enclosure containing a hermetically sealed region, the enclosure configured to be implanted on or within a recipient. The apparatus further includes circuitry within the hermetically sealed region and configured to generate signals. The apparatus further includes at least one heating element configured to receive the signals and to generate heat in response to the signals. The apparatus further includes at least one flow control element outside the hermetically sealed region and configured to respond to the heat by controlling a flow of liquid through at least one cannula to controllably administer the liquid internally to the recipient.
-
公开(公告)号:US20230398349A1
公开(公告)日:2023-12-14
申请号:US18250340
申请日:2021-10-15
Applicant: Cochlear Limited
Inventor: Paul Michael Carter , Daniel Smyth , Wolfram Frederik Dueck , Stefan Jozef Mauger
CPC classification number: A61N1/327 , A61N1/36038 , A61N1/0541 , A61B5/0536 , A61B5/388 , A61B5/686 , A61B5/0071
Abstract: A method includes receiving information regarding a position and/or an orientation of an implantable device relative to a body portion of a recipient during and/or after implantation of at least a portion of the device on and/or into the body portion. The device includes a plurality of electrodes configured to apply electroporation to first cells of the body portion while not damaging second cells of the body portion. The method includes estimating, in response at least in part to the information, first interactions of the electrodes with respect to the first cells. The method further includes estimating, in response at least in part to the information, second interactions of the electrodes with respect to the second cells. The method further includes generating, in response at least in part to the estimated first interactions and the estimated second interactions, values of electrical parameters configured to be provided to the plurality of electrodes to electroporate to the first cells while not damaging the second cells.
-
公开(公告)号:US12285590B2
公开(公告)日:2025-04-29
申请号:US16649861
申请日:2018-09-21
Applicant: COCHLEAR LIMITED
Inventor: Daniel Smyth , Jonathon Kirk , Wolfram Frederik Dueck , Joris Walraevens
Abstract: A drug delivery device configured to simultaneously interface with a scala tympani and a scala vestibuli of a cochlea, wherein the device can be configured to deliver drug to the cochlea at least in part via a post introduction non-diffusion based delivery, and wherein the device can be configured to induce complete circuit circulation from the scala tympani to the scala vestibuli and/or vice versa, thereby distributing drug within the cochlea.
-
公开(公告)号:US09440073B2
公开(公告)日:2016-09-13
申请号:US14799764
申请日:2015-07-15
Applicant: Cochlear Limited
Inventor: Wolfram Frederik Dueck , Nicholas Charles Kendall Pawsey , Peter Raymond Sibary , Claudia Tasche
CPC classification number: A61N1/36032 , A61N1/0541 , A61N1/36036
Abstract: Presented herein are trans-modiolar stimulation techniques in which stimulation current is sourced (delivered) by at least one intra-cochlear stimulating contact and is sunk at a group of other intra-cochlear stimulating contacts. The group of other intra-cochlear stimulating contacts is positioned (located) across a section of the recipient's modiolus from the intra-cochlear stimulating contact that sources the stimulation. As such, stimulation current generally passes through the modiolus to stimulate spiral ganglion cells and evoke a hearing percept.
Abstract translation: 这里提出的是反式模式刺激技术,其中通过至少一个耳蜗内刺激接触来源(递送)刺激电流并且沉没在一组其他耳蜗内刺激接触处。 其他耳蜗内刺激接触的组被定位(定位)穿过来自刺激的耳蜗内刺激接触的接受者的一部分。 因此,刺激电流通常通过脉络膜刺激螺旋神经节细胞并引起听觉感知。
-
公开(公告)号:US20240181232A1
公开(公告)日:2024-06-06
申请号:US18553787
申请日:2022-03-18
Applicant: Cochlear Limited
Inventor: Daniel Smyth , Wolfram Frederik Dueck
CPC classification number: A61M31/002 , A61F11/00 , A61M2210/0668
Abstract: Presented herein are therapeutic substance delivery devices configured to be inserted into a body chamber of a recipient. The therapeutic substance delivery devices are configured to assume a position in close proximity to a first wall of the body chamber, without affecting body structures located at a second (opposing) side of body chamber.
-
-
-
-
-